title: Characteristics of infective endocarditis in France in 1991. A 1-year survey.
abstract: OBJECTIVE
  To update data on incidence and characteristics of infective endocarditis in France.
  
  
  BACKGROUND
  Numerous studies have shown that the incidence and course of infective endocarditis remain stable in spite of advances in treatment and of prophylactic recommendations.
  
  
  METHODS
  A survey of all consecutive cases of infective endocarditis was conducted over 12 months in all the institutions of three French regions.
  
  
  RESULTS
  Data were collected from 415 cases of definite (32%), probable (53%), and possible (15%) infective endocarditis. The adjusted annual incidence was 24.3 cases per million inhabitants. Thirty-four percent of the patients had no previously known heart disease, 33% had native valve disease, 22% had a prosthetic valve, and 11% had miscellaneous underlying conditions. Infective endocarditis was located solely on the mitral valve in 39%, solely on the aortic valve in 36%, and on the tricuspid valve in 6%. Echocardiography showed a vegetation on the mitral valve in 39%, on the aortic valve in 29%, and on the tricuspid valve in 8%. The causal microorganism was identified in 92%; it was a Streptococcus in 58%, and a Staphylococcus in 23%. Twenty patients were intravenous drug users, and 45 had had a medical or a surgical procedure, which might be associated with the occurrence of infective endocarditis. During the first 2 months after admission, 24% of the patients underwent surgery, and 17% of all patients died.
  
  
  CONCLUSIONS
  Despite medical and surgical advances, infective endocarditis remains frequent and severe in France.
authors.affiliation: Hôpital Louis Pradel, Lyon, France.
authors.forename: F
authors.initials: F
authors.lastname: Delahaye
authors.forename: V
authors.initials: V
authors.lastname: Goulet
authors.forename: F
authors.initials: F
authors.lastname: Lacassin
authors.forename: R
authors.initials: R
authors.lastname: Ecochard
authors.forename: C
authors.initials: C
authors.lastname: Selton-Suty
authors.forename: B
authors.initials: B
authors.lastname: Hoen
authors.forename: J
authors.initials: J
authors.lastname: Etienne
authors.forename: S
authors.initials: S
authors.lastname: Briançon
authors.forename: C
authors.initials: C
authors.lastname: Leport
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D004697:Endocarditis, Bacterial / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000401:mortality; D005260:Female; D005602:France / Q000453:epidemiology; D006306:Health Surveys; D006350:Heart Valve Prosthesis; D006801:Humans; D015994:Incidence; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D016459:Prosthesis-Related Infections / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000401:mortality; D012307:Risk Factors; D013203:Staphylococcal Infections / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000401:mortality; D013290:Streptococcal Infections / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000401:mortality; D015819:Substance Abuse, Intravenous / Q000150:complications / Q000453:epidemiology / Q000401:mortality; D015996:Survival Rate